Skip to content

Effect of ketoacetate aminobutanol prophylactic analgesia on pbmc and postoperative recovery quality in colorectal cancer patients.

Effect of ketoacetate aminobutanol prophylactic analgesia on pbmc and postoperative recovery quality in colorectal cancer patients.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026161
Enrollment
Unknown
Registered
2019-09-24
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

experimental group:ketoacetate aminobutanol prophylactic analgesia
control group:normal saline

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of Shihezi University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. BMI:1825kg/m2; 3. ASA classification level I-II; 4. Preoperative pathology demonstrated colorectal cancer; 5. The patient himself is informed and signs or the family signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Abnormal liver and kidney function, cardiopulmonary insufficiency, or with a history of severe cardiovascular, endocrine system or liver and kidney disease; 2. gastrointestinal ulcer, 3. history of blood system diseases and bleeding, 4. allergy of non-steroidal painkillers, 5. with a history of using mental drugs, opioids or non-steroidal anti-inflammatory drugs; 6. history of long-term hormone use; 7. receiving immunosuppressant and cytological treatment; 8. history of alcohol consumption; 9. history of perioperative transfusion; 10. mental and communication disorders. 11. The length of operation was >= 4 hours.

Design outcomes

Primary

MeasureTime frame
QOR-40 score;Tcr cdr3 length;TCRV;

Secondary

MeasureTime frame
Sex;age;Height;Weight;ASA classification;Operation time;Intraoperative blood loss;Extubation time;PONV;VAS score;Discharge time;Analgesic remedial measures;IL-1ß;IL-6;IL-10;CD3+;CD4+;CD8+;

Countries

China

Contacts

Public ContactTao Jun

Department of Anesthesiology, the First Affiliated Hospital of Shihezi University Medical College

317095976@qq.com+86 15872691332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026